Stanley Druckenmiller acquired 3.07M NewAmsterdam Pharma Company NV shares worth $91.6M. That's 2.83% of their equity portfolio (9th largest holding). The investor owns 2.60% of the outstanding NewAmsterdam Pharma Company NV stock. The stake costed the investor $84.9M, netting the investor a gain of 7.9% so far.